Vitamin D status and ill health

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 4, 2014, Pages 273-274

  Holick, Michael F ^a   Grant, William B ^b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b Sunlight   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; COLECALCIFEROL; PARATHYROID HORMONE; VITAMIN D;

ALZHEIMER DISEASE; BREAST CANCER; CANCER RISK; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; DISEASE MARKER; DISEASES; DOSE RESPONSE; DRUG DOSE COMPARISON; HUMAN; INFLAMMATION; IONIZING RADIATION; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SUN EXPOSURE; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; ANALOGS AND DERIVATIVES; COMPLICATION; VITAMIN D DEFICIENCY;

HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84897468209     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(14)70044-0     Document Type: Letter

References (5)

1. Autier P, Boniol M, Pizot C, Mullie P Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014, 2:76-89.
2. Heaney RP Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 2014, 72:48054.
3. Moukayed M, Grant WB Molecular link between vitamin D and cancer prevention. Nutrients 2013, 5:3993-4023.
4. Lee P, Eisman JA, Center JR Vitamin D deficiency in critically ill patients. N Engl J Med 2009, 360:1912-1914.
5. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003, 88:4623-4632.